Tag: durvalumab
‘Durvalumab’ can improve life span of lung cancer patients
The drug, ‘durvalumab’, can double the overall time someone can survive with an aggressive form of lung cancer from two-and-a-half to five years.
It has...
Follow us
Engage with Experts: Connect with industry leaders, renowned pharmacists, and forward-thinking researchers through exclusive live Q&A sessions and engaging discussions. Tap into their wisdom, ask burning questions, and gain invaluable insights to fuel your passion for pharmacy
Company
Copyright © 2023 Garavi Gujarat Publications Ltd & Garavi Gujarat Publications USA Inc